Skip to content

Intervention Study of Inflammatory Bowel Disease Complicated with Sarcopenia

Research and Intervention Study of Inflammatory Bowel Disease Complicated with Sarcopenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051843
Enrollment
Unknown
Registered
2021-10-07
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease, sarcopenia

Interventions

Nutrition + exercise intervention group:Whey protein 10g/day + resistance exercise training 3 times a week
Placebo + exercise intervention group:Placebo 10g/day + resistance exercise training 3 times a week

Sponsors

Huadong Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Total energy, protein intake, total carbohydrate intake, and total fat intake all reached the Dietary Reference Intakes (DRIs) of Chinese adults aged 18-49 years or the Recommended Nutrients Intakes (RNI) of Chinese adults aged 50-64 years; 2. The nutritional status is low nutritional risk status after screening by the Malnutrition Universal Screening Tool (MUST).

Exclusion criteria

Exclusion criteria: 1. Abdominal pain, diarrhea, blood in the stool, mucus pus and blood in the stool due to milk intolerance; 2. Allergic to milk and whey protein (whey protein + resistance exercise training intervention group), rice and brown rice (rice cereal + resistance exercise training intervention group); 3. Those who cannot eat normally orally due to dysphagia or changes in the anatomical structure of the oropharynx; 4. Those who cannot complete the resistance exercise training 3 times a week for various reasons; 5. Those who have intestinal resection or intestinal fistula; 6. Patients with moderate to severe activity.

Design outcomes

Primary

MeasureTime frame
skeletal muscle mass;

Secondary

MeasureTime frame
grip strength;

Countries

China

Contacts

Public ContactZhao Jiaxi

Huadong Hospital Affiliated to Fudan University

zhaojia_xi@126.com+86 15228225491

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026